Group One Trading
MYOV

Group One Trading’s Myovant Sciences Ltd. MYOV Stock Holding History

Group One Trading’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29,000
Closed -$782K – 8268
2022
Q4 		$782K Sell
29,000
-32,400
-53% -$852K ﹤0.01% 2632
2022
Q3 		$1.1M Sell
61,400
-38,400
-38% -$613K ﹤0.01% 2483
2022
Q2 		$1.24M Buy
99,800
+64,700
+184% +$714K ﹤0.01% 2545
2022
Q1 		$468K Buy
35,100
+10,400
+42% +$139K ﹤0.01% 3883
2021
Q4 		$385K Sell
24,700
-10,900
-31% -$208K ﹤0.01% 4415
2021
Q3 		$799K Sell
35,600
-10,800
-23% -$237K ﹤0.01% 3659
2021
Q2 		$1.06M Sell
46,400
-23,000
-33% -$484K ﹤0.01% 3347
2021
Q1 		$1.43M Sell
69,400
-600
-0.9% -$13.7K ﹤0.01% 2819
2020
Q4 		$1.93M Buy
70,000
+37,300
+114% +$726K ﹤0.01% 2082
2020
Q3 		$459K Sell
32,700
-15,400
-32% -$286K ﹤0.01% 2919
2020
Q2 		$992K Sell
48,100
-9,100
-16% -$124K ﹤0.01% 2029
2020
Q1 		$432K Sell
57,200
-64,800
-53% -$727K ﹤0.01% 2153
2019
Q4 		$1.89M Buy
+122,000
New +$1.23M 0.01% 1322

Other funds holding MYOV

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Group One Trading's MYOV Position: Q3 2022 in Review

Group One Trading sold out of Myovant Sciences Ltd. (MYOV) in Q3 2022, closing a stake of 10,323 shares — an estimated $165K sold.

Group One Trading first reported a position in MYOV in Q4 2019 and held it in 10 quarters. The position peaked at $674K in Q4 2019. 98 funds tracked by Wall St. Rank hold MYOV as of Q3 2022.

  • Group One Trading reported no remaining Myovant Sciences Ltd. position as of Q3 2022 after selling out during the quarter.
  • Group One Trading sold 10,323 Myovant Sciences Ltd. shares in Q3 2022, an estimated $165K.
  • Group One Trading first reported a position in Myovant Sciences Ltd. in Q4 2019 and held it in 10 quarters.
  • Group One Trading's Myovant Sciences Ltd. position peaked at $674K in Q4 2019.
  • 98 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2022.

Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.